Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

Users on Facebook, Instagram and X have shared the same “BREAKING NEWS” message, claiming that “A CURE FOR HIV/AIDS HAS JUST ...

In a significant breakthrough, scientists at Johns Hopkins University have discovered that gene therapy could be a key to forcing HIV into a permanent dormant state, potentially offering a long-term, ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

The drug nearly eliminated HIV's spread among people who received an injection every six months. But some experts worry about how accessible it will be.